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Introduction
Delayed enhancement (DE) on contrast-enhanced cardio-
vascular magnetic resonance (CMR), representative of
myocardial fibrosis is relatively common in the left ventri-
cle (LV) of patients with hypertrophic cardiomyopathy
(HCM). However, the clinical significance and arrhyth-
mogenic potential of this finding remains unresolved.
Purpose
Therefore, the objective of the present study was to assess
the prevalence and frequency of spontaneous tachyar-
rhythmias in HCM with regard to DE on contrast-
enhanced CMR.
Methods
A total of 177 HCM patients (age 41 ± 16 years; 95%
asymptomatic or mildly symptomatic) were evaluated by
24-hour ambulatory Holter ECG and contrast-enhanced
CMR.
Results
A total of 72 patients (41%) had DE (transmural in 39/
72), occupying 8.5 ± 7.8 percent of the LV wall. Presence
of premature ventricular contractions (PVCs), couplets
and nonsustained ventricular tachycardia (NSVT) were
more common in patients with DE than those without DE
(PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28%
vs. 4%; p < 0.0001–0.007). Patients with DE also had
greater numbers of PVCs (202 ± 655 vs. 116 ± 435), cou-
plets (1.9 ± 5 vs. 1.2 ± 10), and NSVT runs (0.4 ± 0.8 vs.
0.06 ± 0.4) than did non-DE patients (all p < 0.0001); DE
was an independent predictor of NSVT (relative risk 7.3,
95% CI 2.6 – 20.4; p < 0.0001). Of note, however, extent
(%) of DE was similar in patients with and without PVCs
(8.2% vs. 9.1%; p = 0.93), couplets (8.5% vs. 8.4%; p =
0.99) and NSVT (8.3% vs. 8.5%; p = 0.35).
Conclusion
In this large HCM cohort with no or only mild symptoms,
myocardial fibrosis detected by CMR was associated with
greater likelihood and increased frequency of ventricular
tachyarrhythmias (including NSVT) on ambulatory Hol-
ter ECG. Therefore, contrast-enhanced CMR identifies
HCM patients having increased susceptibility to ventricu-
lar tachyarrhythmias with implications for sudden death
risk stratification.
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